drugset

drugset / Trial / NCT00667004

Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease

NCT00667004 ↗

Phase 2 Completed 183 enrolled Bausch & Lomb Incorporated

RandomizedParallel-groupDouble-blindTreatment

Summary

Efficacy study of ecabet ophthalmic solution in dry eye disease

Timeline

Start: 2008-03-22
Primary completion: 2008-09-12
Completion: 2008-09-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ecabet	Small molecule	—	—

Indications